Shareholders Approve All-Cash Acquisition by Kingswood and Forager at $3.65/Share
QIPT has more than doubled off its 52-week low of $1.35.
Summary
Quipt Home Medical Corp. shareholders overwhelmingly approved the all-cash acquisition by affiliates of Kingswood Capital Management and Forager Capital Management for $3.65 per share, moving the company closer to going private.
Key Events · M&A and Partnerships · QIPT
-
Shareholder Approval of Acquisition
Shareholders voted to approve the plan of arrangement for the acquisition of all outstanding shares by affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC. The Arrangement Resolution received 98.9% of votes cast by shareholders, and 98.7% after excluding minority votes.
-
Acquisition Terms Confirmed
The acquisition is for cash consideration of US$3.65 per share, as previously announced. This finalizes the shareholder consent for the terms of the deal.
-
Next Steps Towards Closing
The company is scheduled to seek a final order from the Supreme Court of British Columbia approving the Arrangement on March 5, 2026, with completion expected in the near term, subject to other closing conditions.
Analysis · QIPT · Industrial Applications And Services
Quipt Home Medical Corp. shareholders have overwhelmingly approved the plan of arrangement for the company's acquisition by affiliates of Kingswood Capital Management and Forager Capital Management. This vote is a critical step towards the company going private, with shareholders set to receive $3.65 per share in cash. The approval, with over 98% of votes cast in favor, indicates strong shareholder support for the transaction. The company is now scheduled to seek a final court order on March 5, 2026, with the acquisition expected to close in the near term, effectively concluding the investment thesis for current shareholders.
At the time of this filing, QIPT was trading at $3.64 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $161.9M. The 52-week trading range was $1.35 to $3.64. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.